Atorvastatin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Atorvastatin and local guidelines before prescribing.
Mechanism
HMG-CoA reductase inhibitor lowering hepatic cholesterol synthesis and increasing LDL receptors.
Uses
Primary and secondary cardiovascular prevention, hypercholesterolaemia.
Dosing
- Primary prevention (QRISK3 10% or more) - atorvastatin 20 mg ; secondary prevention - atorvastatin 80 mg (NICE NG238).
Cardiology: Anatomy Physiology and Pharmacology - Atorvastatin | HMG-CoA reductase inhibitor; 20 mg primary, 80 mg secondary prevention; LFTs at 0, 3, 12 months; clarithromycin interaction.
Cardiology: Anatomy Physiology and Pharmacology - High-intensity statin (atorvastatin 80 mg).
Cardiology: Cardiology Emergencies - Primary prevention: If QRISK3 is 10% or more, offer atorvastatin 20 mg daily after a shared discussion.
Cardiology: Ischaemic Heart Disease (ACS) › 1.05 Risk Factors and Risk Assessment
4 more dose entries from the chapters
- High-intensity statin: Atorvastatin 80 mg daily.
Cardiology: Ischaemic Heart Disease (ACS) › 1.08 Drug Treatment of Stable Angina - Type 2: Atorvastatin 20 mg if QRISK3 is 10% or more.
Endocrinology: Diabetes - Type 1: Offer atorvastatin 20 mg if aged over 40, diabetes for more than 10 years, nephropathy, or other cardiovascular risk factors.
Endocrinology: Diabetes - QRISK3 of 10% or more: Offer atorvastatin 20 mg after discussing lifestyle.
Endocrinology: Lipids and obesity
Side effects
Myalgia, raised ALT, GI upset; rarely myopathy, rhabdomyolysis, new-onset diabetes.
Interactions
Clarithromycin, azole antifungals and ciclosporin raise levels; grapefruit juice in large amounts; fibrates increase myopathy risk.
Contraindications and cautions
Active liver disease; caution in alcohol excess
Monitoring
Lipids, ALT at baseline and 3 months, CK if symptoms
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
No renal adjustment
Overdose and reversal
Supportive
Special advice
Baseline lipids and LFT; report unexplained muscle pain; check CK if symptomatic; avoid in pregnancy.
More from the textbook: uses, cautions and other points
- Clarithromycin and erythromycin - pause simvastatin and atorvastatin during the course.
Endocrinology: Lipids and obesity - Grapefruit juice - simvastatin and atorvastatin.
Endocrinology: Lipids and obesity - CK 12,000 and progressive weakness after stopping atorvastatin | Anti-HMGCR necrotising myopathy
Neurology: Neuromuscular disease - 2. A 28-year-old woman with hypertension on ramipril and atorvastatin wants to become pregnant. Answer: Pre-conception medication review.
Obstetrics - CK 8,000 persisting months after stopping atorvastatin | Anti-HMGCR necrotising myopathy
Rheumatology: Connective tissue diseases - Interactions - clarithromycin and erythromycin are strong CYP3A4 inhibitors : simvastatin and atorvastatin (myopathy - pause the statin), warfarin , DOACs, colchicine (dangerous), theophylline, carbamazepine, ciclosporin and tacrolimus , some calcium channel blockers; azithromycin has fewer interactions.
ID: How Infection Happens
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (3 mentions)
- Cardiology: Cardiology Emergencies (1 mention)
- Cardiology: Ischaemic Heart Disease (ACS) (6 mentions)
- Endocrinology: Diabetes (4 mentions)
- Endocrinology: Lipids and obesity (8 mentions)
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Stroke Emergencies (3 mentions)
- Neurology: Neuromuscular disease (1 mention)
- Renal: Anatomy, Physiology and Pharmacology (2 mentions)
- Renal: Chronic Kidney Disease (4 mentions)
- Obstetrics (1 mention)
- Rheumatology: Connective tissue diseases (1 mention)
- ID: How Infection Happens (2 mentions)
- ID: HIV, viral hepatitis and blood-borne viruses (2 mentions)
- Surgery: Vascular surgery (2 mentions)
- Medicine of the older adult: .Prescribing and deprescribing in older people (4 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (2 mentions)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical Immunology: Autoimmunity, autoantibodies and complement (1 mention)
- Clinical Genetics: Cancer genetics and inherited cardiovascular conditions (1 mention)
- Integrated cardiology chapter (6 mentions)
- General Practice: Long-term conditions, multimorbidity and polypharmacy (5 mentions)